Our Pricing

Your First Week with Mounjaro: Initial Side Effects

Published on: June 03, 2026

Understanding mounjaro side effects first week uk treatment can help you prepare for your weight loss journey with confidence. Most patients starting Mounjaro (tirzepatide) experience mild to moderate side effects during the initial weeks, with gastrointestinal symptoms being the most common. Our UK-registered clinical team at Cured Pharmacy has supported thousands of patients through their first injection, and this guide provides practical, evidence-based advice on what to expect and how to manage common reactions.

Common Mounjaro Side Effects in Week One

During your first week on Mounjaro, your body is adjusting to tirzepatide's dual action on GIP and GLP-1 receptors, which slow gastric emptying and regulate appetite signals [1]. This mechanism, while highly effective for weight loss, typically produces temporary digestive side effects as your system adapts.

In the SURMOUNT-1 clinical trial, approximately 80% of participants experienced at least one gastrointestinal side effect during the initial titration period, though most were mild to moderate in severity [1]. The most frequently reported symptoms during week one include nausea (affecting 25-30% of patients), reduced appetite, mild abdominal discomfort, and occasional loose stools [2].

These initial reactions are generally most noticeable 24-48 hours after your first injection and typically diminish within 3-5 days as your body adapts. Starting with the lowest maintenance dose of 2.5mg significantly reduces the likelihood of severe symptoms compared to higher initial doses [1].

Managing Nausea and Digestive Discomfort

Nausea represents the most common side effect during your first week with Mounjaro, but several evidence-based strategies can minimise discomfort. Eating smaller, more frequent meals throughout the day rather than three large portions helps accommodate the slower gastric emptying that tirzepatide produces [3].

Our superintendent pharmacist Tarun Kumar recommends avoiding high-fat, spicy, or heavily processed foods during your first fortnight, as these can exacerbate nausea and abdominal discomfort. Instead, focus on bland, easily digestible options such as plain rice, toast, bananas, and lean proteins. Staying well-hydrated with small sips of water throughout the day also helps, though drinking large volumes immediately after meals may worsen symptoms.

If nausea persists beyond the first week or becomes severe enough to prevent fluid intake, contact your prescriber immediately. Persistent vomiting can lead to dehydration and may require temporary dose adjustment or anti-nausea medication prescribed by your UK clinician [2].

When Nausea Requires Medical Attention

While mild nausea is expected, certain symptoms warrant immediate clinical review. Contact your prescriber if you experience persistent vomiting lasting more than 24 hours, inability to keep fluids down, signs of dehydration (dark urine, dizziness, extreme thirst), or severe abdominal pain that doesn't resolve with rest [3]. These symptoms, though uncommon, may indicate that your starting dose needs adjustment or that you're experiencing a rare adverse reaction requiring medical assessment.

Changes in Appetite and Eating Patterns

One of the most immediate effects you'll notice during your first week on Mounjaro is a significant reduction in appetite and earlier feelings of fullness. This isn't a side effect to manage but rather the primary therapeutic mechanism through which tirzepatide promotes weight loss [1].

Many patients report feeling satisfied after consuming 30-50% less food than their usual portions, with reduced cravings for high-calorie foods and decreased food-focused thoughts throughout the day. In clinical trials, participants described this effect as a 'quieter' relationship with food rather than constant hunger suppression [4].

Despite reduced appetite, maintaining adequate nutrition remains essential. Aim for at least 1,200-1,500 calories daily from nutrient-dense sources, prioritising protein intake (60-80g daily) to preserve lean muscle mass during weight loss. Your UK prescriber may recommend working with a dietitian to optimise your nutritional plan whilst taking Mounjaro, ensuring you meet micronutrient requirements even with smaller meal volumes [4].

Mounjaro Side Effects First Week UK: Injection Site Reactions

Local reactions at the injection site affect approximately 5-10% of patients during their first week with Mounjaro. These typically present as mild redness, slight swelling, or tenderness at the injection location, usually resolving within 24-48 hours without intervention [2].

To minimise injection site reactions, rotate your injection location each week between your abdomen, thigh, and upper arm. Avoid injecting into areas with visible bruising, scarring, or skin irritation. Allow the pen to reach room temperature before injection (remove from the fridge 30 minutes beforehand) and inject slowly over 5-10 seconds rather than rapidly pressing the plunger [3].

If you notice persistent swelling, spreading redness, warmth at the site, or any signs of infection, contact your prescriber for assessment. Whilst rare, allergic reactions to tirzepatide can occur and require immediate medical evaluation if accompanied by breathing difficulties, facial swelling, or widespread rash [2].

Proper Injection Technique for First-Time Users

Correct injection technique significantly reduces the likelihood of site reactions and ensures optimal medication delivery. Always inject into subcutaneous tissue (the fatty layer beneath your skin) rather than muscle. Pinch a fold of skin gently, insert the needle at a 90-degree angle, and maintain steady pressure until the dose counter shows zero. Never inject through clothing, and always use a fresh needle for each injection as recommended by the MHRA guidelines for subcutaneous medications [3].

Fatigue and Energy Levels During Initial Treatment

Some patients report feeling more tired than usual during their first week on Mounjaro, particularly if experiencing reduced appetite or mild nausea that affects normal eating patterns. This temporary fatigue typically results from the combination of caloric reduction and your body's metabolic adjustment to tirzepatide rather than a direct drug effect [4].

Maintaining stable blood sugar levels becomes particularly important during this adjustment period. Even if your appetite is suppressed, eating small amounts of complex carbohydrates every 3-4 hours helps prevent energy crashes. Good options include oatcakes, wholegrain crackers, or small portions of brown rice with lean protein.

Most patients find their energy levels stabilise or even improve by week two as their body adapts to the new eating pattern and begins utilising fat stores more efficiently. If fatigue persists beyond the first fortnight or becomes severe enough to interfere with daily activities, consult your prescriber to rule out other contributing factors such as inadequate hydration or nutrient deficiencies [4].

Starting Mounjaro What to Expect: Long-Term Side Effect Profile

Understanding that first-week side effects are temporary helps maintain realistic expectations during your weight loss journey. Clinical trial data from the SURMOUNT studies demonstrates that gastrointestinal side effects peak during the initial 4-8 weeks of treatment and typically resolve or significantly diminish as your body adapts to tirzepatide [1].

By week 12, most patients report minimal ongoing side effects, with the majority continuing treatment due to significant weight loss progress and improved metabolic markers. In the SURMOUNT-1 trial, participants achieved an average 15.7% body weight reduction at 72 weeks on the 10mg maintenance dose, with only 4.3% discontinuing due to adverse events [1].

At Cured Pharmacy, Mounjaro is available from £124.99 with transparent upfront pricing and free clinical consultation by UK-registered prescribers. All patients receive comprehensive support materials covering side effect management, injection technique, and nutritional guidance. Your treatment requires ongoing clinical assessment, with prescribers monitoring your progress and adjusting doses based on your individual response and tolerability [2].

Comparing Mounjaro to Alternative Weight Loss Treatments

If first-week side effects with Mounjaro prove challenging, alternative GLP-1 treatments may offer different tolerability profiles. Wegovy (semaglutide) provides similar weight loss outcomes with a slightly different side effect pattern, whilst Saxenda (liraglutide) uses daily injections at lower individual doses, which some patients find easier to tolerate initially. Your UK prescriber can discuss these alternatives during your consultation, ensuring you receive the most appropriate treatment for your individual circumstances and medical history.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
3. Dahl, D., et al. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity: Technology appraisal guidance. NICE. https://www.nice.org.uk/guidance/indevelopment/gid-ta11235 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Side effects vary between individuals, and this guide does not replace personalised medical advice from your prescriber.